Fourth quarter 2025 revenue was $0.5 million, with full year 2025 revenue reaching $2.4 million. Net loss for Q4 2025 was $17.6 million, an improvement from $33.1 million in Q4 2024. Full year 2025 net loss was $101.3 million, slightly higher than $101.0 million in FY 2024. Adjusted EBITDA for Q4 2025 was negative $17.0 million, an improvement from negative $25.1 million in Q4 2024. Adjusted EBITDA for full year 2025 was negative $80.7 million, an improvement from negative $92.8 million in FY 2024. Cash and cash equivalents and investments in marketable securities totaled $215.8 million as of December 31, 2025. The list price for the Proteus platform was announced at $425,000. 2026 financial guidance includes approximately $1.0 million in revenue, adjusted total operating expenses of $98.0 million or less, and total cash usage of $93.0 million or less. The Proteus development program remains on track for a year-end 2026 launch.